| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-10 |